US Patent Issued to CSL Innovation on March 17 for "Factor IX variants and uses thereof in therapy" (German, Australian Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,552, issued on March 17, was assigned to CSL Innovation Pty Ltd (Melbourne, Australia).

"Factor IX variants and uses thereof in therapy" was invented by Philipp Claar (Marburg, Germany), Thomas Weimer (Gladenbach, Germany), Walid Azar (Melbourne, Australia), Holger Lind (Marburg, Germany) and Marco Hofmann (Lahntal, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides Factor IX variants, molecules comprising the variants, nucleic acids encoding the variants, compositions comprising the variants or the nucleic acids encoding the variants, and their use in methods for the modulation of hemostasis, for example in the prophyla...